Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples